{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T06:43:06Z","timestamp":1695105786820},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Methotrexate (MTX) is a commonly used agent in the treatment of oncology patients whose clearance depends on renal health maintaining glomerular filtration and tubular secretion. Thus concomitant use of other drugs that utilize the same mechanism of clearance are generally avoided as this may contribute to increased MTX-associated toxicity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Observation:<\/jats:title>\n            <jats:p>Herein, we describe the use of low-dose aspirin with high-dose MTX in a patient with osteosarcoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Concomitant aspirin use did not affect the clearance of high-dose MTX and the patient did not experience any MTX-related toxicity including mucositis or renal impairment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000000939","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T19:08:51Z","timestamp":1504897731000},"page":"e392-e393","source":"Crossref","is-referenced-by-count":1,"title":["Concomitant Administration of High-dose Methotrexate and Low-dose Aspirin Without Any Delay in Methotrexate Clearance in a Patient With Osteosarcoma: A Case Report and Review of the Literature"],"prefix":"10.1097","volume":"40","author":[{"given":"Samuele","family":"Renzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Tsimerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevan","family":"Hopyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/clinchem\/42.8.1322","article-title":"Concepts in use of high-dose methotrexate therapy","volume":"42","author":"Treon","year":"1996","journal-title":"Clin Chem"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1586\/ecp.11.57","article-title":"Pharmacokinetic drug-drug interactions with methotrexate in oncology","volume":"4","author":"Leveque","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.2015-0164","article-title":"Preventing and managing toxicities of high-dose methotrexate","volume":"21","author":"Howard","year":"2016","journal-title":"Oncologist"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000327372","article-title":"Suspicion of drug-drug interaction between high-dose methotrexate and proton pump inhibitors: a case report\u2014should the practice be changed?","volume":"57","author":"Ranchon","year":"2011","journal-title":"Chemotherapy"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejphar.2008.08.023","article-title":"Evaluation of the interaction between nonsteroidal anti-inflammatory drugs and methotrexate using human organic anion transporter 3-transfected cells","volume":"596","author":"Maeda","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003088-198611030-00004","article-title":"Pharmacokinetic drug interactions of commonly used anticancer drugs","volume":"11","author":"Balis","year":"1986","journal-title":"Clin Pharmacokinet"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3899\/jrheum.090153","article-title":"Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review","volume":"37","author":"Bourre-Tessier","year":"2010","journal-title":"J Rheumatol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S1470-2045(16)30214-5","article-title":"Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial","volume":"17","author":"Marina","year":"2016","journal-title":"Lancet Oncol"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00006534-197606000-00009","article-title":"The synergistic effect of salicylates on methotrexate toxicity","volume":"57","author":"Mandel","year":"1976","journal-title":"Plast Reconstr Surg"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3899\/jrheum.120345","article-title":"Safety of nonsteroidal antiinflammatory drugs and\/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review","volume":"90","author":"Colebatch","year":"2012","journal-title":"J Rheumatol Suppl"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201808000-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:15:30Z","timestamp":1695010530000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201808000-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000939","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}